Virtual Conference for Life Sciences Companies Broadcast Live December 17th, 2020

Company executives will share corporate vision and answer audience questions at

NEW YORK, Dec. 14, 2020 (GLOBE NEWSWIRE) -- Life Sciences Investor Forum today announced the agenda for its quarterly event for public and private companies, investors and industry professionals from around the world. This day-long virtual event will showcase live company presentations and interactive discussions focused on the life sciences industry.

Individual investors, institutional investors, advisors and analysts are invited to attend. The program opens at 9:15 AM ET on Thursday, December 17th with the first live webcast at 9:30 AM ET.


It is recommended that investors pre-register and run the online system check to expedite participation and receive event updates. There is no cost to log-in, attend the live presentations or ask questions.

Agenda and presenting companies:

Eastern Time
Company NameTicker(s)
9:30 AMKane Biotech Inc.OTCQB: KNBIF | TSX-V: KNE
10:00 AMTheralase Technologies Inc.OTCQB: TLTFF | TSX-V: TLT
10:30 AMCaladrius Biosciences, Inc.NASDAQ: CLBS
11:00 AMPressure BioSciences, Inc.OTCQB: PBIO
11:30 AMHLS Therapeutics Inc.TSX: HLS
12:00 PMBionexus Gene Lab Corp.OTCQB: BGLC
12:30 PMVolitionRx LimitedNYSE AMERICAN: VNRX
1:00 PMXPhyto Therapeutics Corp.OTCQB: XPHYF | CSE: XPHY | FSE: 4XT

To facilitate investor relations scheduling and for more information about the program, please visit

About Life Sciences Investor Forum
Life Sciences Investor Forum is the leading proprietary investor conference series that provides an interactive forum for Life Sciences companies to meet with and present directly to investors.

A real-time solution for investor engagement, Life Sciences Investor Forum is powered by Intrado Digital Media and specifically designed for more efficient investor access. Replicating the look and feel of on-site investor conferences, Life Sciences Investor Forum combines leading-edge conferencing and investor communications capabilities with a comprehensive global investor audience network.


Contact Data